Catalyst Wire Dossier Catalyst Wire Dossier

Duvyzat

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for Duvyzat, covering 2024-03-21 to 2026-07-03. Get the full timeline:

Most recent: EMA Authorised: Duvyzat (givinostat hydrochloride monohydrate) — Italfarmaco S.p.A.

See pricing